TOP TIERMARKET NEWSWIRE
News & sentiment

VANDA PHARMACEUTICAL (VNDA) — News & AI sentiment

VANDA PHARMACEUTICAL (VNDA) news roundup. 3 stories in the past week, 20 over 30 days. Average 30-day sentiment is 51.3/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
3
avg sentiment 56.7/100
30d stories
20
avg sentiment 51.3/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

VNDA news in the last 24 hours, 7 days, 30 days and 90 days

How much VNDA coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowVNDA storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days356.7/100VNDA headlines →
Last 30 days2051.3/100VNDA headlines →
Last 90 days3652.1/100VNDA headlines →

Latest stories on VNDA

1d ago
1d ago
7d ago
Oct 15
Oct 15
Oct 14
Oct 14
Oct 14
Oct 14
Wainwright reiterates Buy on Vanda stock after sleep disorder trial
Investing.com Analyst Ratings61 · neutralanalyst
Oct 5
Oct 2
Oct 1
Sep 30
Sep 30
Sep 30
Sep 30
Why is Vanda Pharmaceuticals stock surging today?
Investing.com Markets50 · neutralgeneral
Sep 29
Sep 29
Sep 29
Sep 29
Oppenheimer initiates Vanda Pharmaceuticals stock with outperform rating
Investing.com Analyst Ratings61 · neutralanalyst
Sep 23
Sep 23
Sep 2
Aug 24
Aug 24
Open VNDA in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →